RECENT NEWS

bioAffinity Technologies has announced a collaboration with Pictor to support development and commercialisation of bioAffinity Technologies’ next-generation diagnostic tests designed to provide a more complete picture of lung inflammation in patients with asthma and chronic obstructive pulmonary disease (COPD).

The Institute of Tropical Medicine (ITM) in Antwerp is receiving an additional €2 million in funding from the Belgian Directorate-General for Development Cooperation and Humanitarian Aid (DGD) to strengthen research and control efforts against the mpox virus (pictured) in the Democratic Republic of the Congo (DRC).

Submissions for Lab Innovations’ Lab Awards, which recognise the achievements and successes of individuals, laboratories and suppliers over the past year, remain open until August 14.

Molecular diagnostics firm Cepheid will unveil the third generation of the GeneXpert system at the upcoming Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting.

En Carta Diagnostics has raised €5 million in financing to fund regulatory certification, industrialisation and commercial launch in Europe and the US of its at-home molecular diagnostics.

Researchers at Loughborough University are uncovering new evidence that exercise may help counteract the cancer-promoting effects of fat cells. The research uses advanced 3D cell culture models and bioluminescence-based assay technology from Promega to generate physiologically relevant data that traditional 2D culture models cannot replicate.

The National Pathology Imaging Co-operative (NPIC) has gone live with a new hospital site, bringing the total number of connected sites across England to 15. Further sites are expected to join later this year.

Revvity has announced the development of the T-SPOT A201, a next-generation high-throughput automated platform designed to support the performance advantages of T-SPOT.TB testing for large-volume clinical laboratories, enabling a reliable, accurate solution for latent tuberculosis (TB) detection.

A new study from a team including University of Nebraska–Lincoln researchers is the first to show metabolites produced by certain bacteria in the gut can positively impact the body’s immune response to cancer.

The Government has shared a new Quality Strategy for NHS-funded Care in England. Developed by the National Quality Board, the strategy aims to put quality at the centre of the NHS’s work, providing a new structured approach to making quality the organising principle for all NHS activity in England over the next decade.

The Joint Committee on Vaccination and Immunisation (JCVI) has published a new recommendation and additional considerations to Government on a routine meningococcal B programme for adolescents.

CellCarta, a leading global contract research organisation (CRO) laboratory, has announced the launch of its Global Digital Pathology and AI Consortium, a curated ecosystem of leading digital pathology, artificial intelligence and precision diagnostics innovators designed to help biopharma sponsors accelerate biomarker discovery.

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2025–26 Annual Report and Accounts highlighting a year of strong and consistent delivery.

The NHS is to screen all newborns for the genetic condition spinal muscular atrophy (SMA), starting later this year.

Wearable devices have transformed how people track exercise, sleep, heart rate and other vital signs. Researchers at King Abdullah University of Science and Technology (KAUST) are now exploring whether similar technologies could one day help monitor medicines inside the body.

Findings from the landmark Articulate Pro study have now been published, marking a major milestone for the use of artificial intelligence (AI) in NHS histopathology laboratories and demonstrating its potential to improve and standardise prostate cancer diagnosis.

Leica Biosystems, an operating company of Danaher, and a leader in anatomic pathology solutions advancing precision cancer diagnostics, has announced it has entered into a definitive agreement to acquire privately held StatLab Medical Products, a leading global developer and manufacturer of anatomical pathology products, from Linden Capital Partners and Audax Private Equity.

As part of an ongoing trial, the use of drones to deliver blood samples for urgent testing is now embedded as an essential part of the South West London Pathology (SWLP) modernisation agenda, with expansion planned to additional hospital and GP sites.

Hologic has announced that its Aptima HPV Assay received an expanded CE-IVDR marking in the European Union and the UK and is now approved for self-collected vaginal samples using the Aptima Multitest Specimen Collection Kit.

Launching one year on from the publication of NHS England’s 10 Year Plan for Health, this joint white paper from The Royal College of Pathologists and Roche Diagnostics provides recommendations for delivering the ‘three shifts’.